Mesalamine 4 Gm/60 ml/Budesonide 2 mg/60 ml Enema is a ready-to-use liquid formulation, contained in pre-filled enema bottles for rectal administration. This convenient and hygienic method provides a measured dose of the solution for easy and controlled application, without the need for additional preparation. It is a compounded medication used for the targeted treatment of Ulcerative Colitis, Crohn's Disease, Proctitis, Proctosigmoiditis, and Diverticulitis.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Mesalamine 4 Gm/60 ml/Budesonide 2 mg/60 ml Enema is a specially compounded medication designed to treat a range of inflammatory bowel diseases, including Ulcerative Colitis, Crohn's Disease, Proctitis, Proctosigmoiditis, and Diverticulitis. This unique formulation combines the anti-inflammatory properties of mesalamine with the corticosteroid budesonide, creating a potent combination that effectively reduces inflammation and alleviates the symptoms associated with these conditions.
The medication is contained in a ready-to-use liquid formulation within pre-filled enema bottles. This method of delivery allows for direct application of the medication to the affected area, providing rapid symptom relief. The pre-filled enema bottles offer a measured dose of the solution, ensuring easy and controlled application without the need for additional preparation, making it a convenient and hygienic method for targeted treatment.
This formulation can be used as a standalone treatment or in conjunction with other medications to provide a comprehensive approach to managing these diseases. However, patients should be aware that this medication may cause side effects such as nausea, vomiting, and abdominal pain. It is also important to note that this medication may interact with other drugs, so it is crucial to consult with a healthcare provider before starting this treatment.
Healthcare providers should be aware that this is a compounded medication, which may have potential for drug interactions and side effects. It is also important to consider the potential for drug incompatibilities.
If you have any questions about this formulation or its use in treating these diseases, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is ready to assist you with any queries you may have.
This compounded formulation of Mesalamine 4 Gm/60 ml/Budesonide 2 mg/60 ml Enema is a ready-to-use liquid solution, specifically designed for rectal administration. It is contained in pre-filled enema bottles, providing a convenient and hygienic method for targeted treatment of various gastrointestinal conditions such as Ulcerative Colitis, Crohn's Disease, Proctitis, Proctosigmoiditis, and Diverticulitis.
Mesalamine, an anti-inflammatory agent, works by reducing inflammation in the lining of the intestines. Budesonide, a corticosteroid, aids in reducing inflammation and suppressing the immune system. The combination of these two medications can help alleviate symptoms associated with these diseases, including abdominal pain, diarrhea, and rectal bleeding.
It is crucial to understand that this formulation is not intended for treating acute flare-ups of these diseases. It is designed for maintenance therapy and may take several weeks to start working, with full effects potentially visible after several months. Therefore, patience and consistent use are key to achieving the desired therapeutic outcomes.
Patients should also be aware of potential side effects, which may include nausea, vomiting, headache, and dizziness. If any of these side effects occur, it is recommended to contact a healthcare provider immediately. This formulation is a significant advancement in the treatment of these disease states, offering a measured dose of the solution for easy and controlled application without the need for additional preparation.
Mesalamine 4 Gm/60 ml/Budesonide 2 mg/60 ml Enema is a compounded formulation designed to treat a range of inflammatory bowel diseases such as Ulcerative Colitis, Crohn's Disease, Proctitis, Proctosigmoiditis, and Diverticulitis. This formulation combines two potent medications, Mesalamine and Budesonide, both of which work synergistically to reduce inflammation in the intestines. Mesalamine is an anti-inflammatory drug that targets inflammation in the intestinal lining, while Budesonide, a corticosteroid, reduces inflammation and suppresses the immune system. Together, these medications help alleviate the symptoms associated with these diseases.
The administration of this medication is rectal, typically once or twice daily as per the healthcare provider's instructions. The patient is advised to lie on their left side, with their knees bent and head slightly elevated. The enema is then inserted into the rectum, and the solution is slowly released. It is recommended that the patient remains in this position for at least 15 minutes to ensure optimal absorption of the medication. Following the administration, the patient should continue to lie down for a minimum of 30 minutes before getting up.
Adherence to the prescribed dosage and duration of treatment is crucial for the effectiveness of this medication. It is not advisable to use more or less of the medication than prescribed, or to use it for a longer period than recommended by your healthcare provider. If you have any queries or concerns about the use of this medication, it is important to consult with your healthcare provider or pharmacist.
This is a ready-to-use liquid formulation contained in pre-filled enema bottles. It is designed for rectal administration and is used for the targeted treatment of constipation, bowel cleansing, or medication delivery.
This formulation is administered rectally. It comes in a pre-filled enema bottle, providing a convenient and hygienic method for application.
This formulation is used for the targeted treatment of constipation, bowel cleansing, or medication delivery. It offers a measured dose of the solution for easy and controlled application.
No, you do not need to prepare anything before using this formulation. It comes in a pre-filled enema bottle, ready for use.
The formulation offers a measured dose of the solution for easy and controlled application. You do not need to worry about measuring the dose yourself.
Yes, this formulation is hygienic to use. It is contained in pre-filled enema bottles, which are designed to be a convenient and hygienic method for application.
Yes, this formulation can be used for medication delivery. It is designed for rectal administration, which allows for targeted treatment.
Each enema bottle contains 60 ml of the solution.
The active ingredients in this formulation are Mesalamine and Budesonide. Each 60 ml of the solution contains 4 Gm of Mesalamine and 2 mg of Budesonide.
Yes, this formulation can be used for bowel cleansing. It is designed for rectal administration, which allows for targeted treatment.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert contents of enema rectally